EcoDrugPlus

Leukotriene B4 Receptor 2a

Ensembl ID : ENSEEEG00000011360
Gene Symbol: LTB4R2A
1 Cross references
159 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSEEEG00000008207
Gene Symbol: KDM1A
4 Cross references
214 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSEEEG00000013520
Gene Symbol: LOXL2A
4 Cross references
210 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSEEEG00000023212
Gene Symbol: LOXL2B
4 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSEEEG00000015347
Gene Symbol: MIF
4 Cross references
235 Possible Orthologues:

Macrophage Stimulating 1 Receptor A

Ensembl ID : ENSEEEG00000006245
Gene Symbol: MST1RA
3 Cross references
196 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSEEEG00000005937
Gene Symbol: MMP14A
2 Cross references
199 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSEEEG00000019134
Gene Symbol: MMP14B
4 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSEEEG00000021740
Gene Symbol: MMP2
4 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSEEEG00000015814
Gene Symbol: MMP9
4 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSEEEG00000019515
Gene Symbol: MTOR
2 Cross references
224 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSEEEG00000017060
Gene Symbol: MC1R
4 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).